Submissions (April 2017)
Date | Description | Download |
---|---|---|
07/04/2017 | FCMA submission for Reforms to the regulatory framework for complementary medicines: Assessment pathways Recommendations Due to the fact that Chinese medicine profession is nationally regulated via statutory regulation, the FCMA recommends that: 1. A separate committee be established solely for Chinese herbal medicines; 2. Chinese Pharmacopeia or Chinese Materia Medica (Zhong Hua Ben Cao) should be adopted by TGA for evaluation of Chinese herbal medicine products; 3. Scientific evidence for evaluation of efficacy of a product be consistent with the level of regulation of medicines.; 4. All existing listed Chinese herbal products should be treated as grandfathered products. |
FCMA submission for CM Reforms |